These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33062840)

  • 1. Donor HLA-DR Drives the Development of De Novo Autoimmunity Following Lung and Heart Transplantation.
    Jankowska Gan E; Agashe VV; Lema DA; Zhou Y; Gonzalez Bosc L; Sullivan JA; Greenspan DS; Burlingham WJ
    Transplant Direct; 2020 Oct; 6(10):e607. PubMed ID: 33062840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
    Keller MR; Haynes LD; Jankowska-Gan E; Sullivan JA; Agashe VV; Burlingham SR; Burlingham WJ
    PLoS One; 2013; 8(11):e79601. PubMed ID: 24265781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.
    Haynes LD; Julliard WA; Mezrich JD; Leverson G; Meyer KC; Burlingham WJ
    Transplantation; 2018 Jul; 102(7):1132-1138. PubMed ID: 29360666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.
    Ooi JD; Petersen J; Tan YH; Huynh M; Willett ZJ; Ramarathinam SH; Eggenhuizen PJ; Loh KL; Watson KA; Gan PY; Alikhan MA; Dudek NL; Handel A; Hudson BG; Fugger L; Power DA; Holt SG; Coates PT; Gregersen JW; Purcell AW; Holdsworth SR; La Gruta NL; Reid HH; Rossjohn J; Kitching AR
    Nature; 2017 May; 545(7653):243-247. PubMed ID: 28467828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen-DR13 and DR15 are associated with short-term lung transplant outcomes.
    Gracon AS; Liang TW; Rothhaar K; Wu J; Wilkes DS
    J Surg Res; 2016 Jun; 203(1):82-90. PubMed ID: 27338538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
    Phelps RG; Jones V; Turner AN; Rees AJ
    Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.
    Angaswamy N; Tiriveedhi V; Sarma NJ; Subramanian V; Klein C; Wellen J; Shenoy S; Chapman WC; Mohanakumar T
    Hum Immunol; 2013 Nov; 74(11):1478-85. PubMed ID: 23876679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen-DR matching improved skin graft survival from transgenic pigs to accommodate SCID mice reconstituted with human peripheral blood mononuclear cells.
    Tu CF; Tai HC; Chen CM; Huang TT; Lee JM; Yang TS; Chen CH; Tseng YL; Chou NK; Lee PH
    Transplant Proc; 2008 Mar; 40(2):578-80. PubMed ID: 18374133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?
    Marrari M; Duquesnoy RJ
    Hum Immunol; 2009 Jun; 70(6):403-9. PubMed ID: 19275922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
    Liu Z; Colovai AI; Tugulea S; Reed EF; Fisher PE; Mancini D; Rose EA; Cortesini R; Michler RE; Suciu-Foca N
    J Clin Invest; 1996 Sep; 98(5):1150-7. PubMed ID: 8787678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of HLA-DR15+ pig skin in SCID mice after reconstitution with human peripheral blood mononuclear cells and under short-term immunosuppression.
    Tai HC; Tu CF; Lee JM; Ho LL; Tseng YL; Chou NK; Yang TS; Weng CN; Lee PH; Chang KJ; Tang YB
    Transplant Proc; 2008 Mar; 40(2):570-3. PubMed ID: 18374131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of human leukocyte antigen-C and -DQ matching on pediatric heart transplant graft survival.
    Butts RJ; Savage AJ; Nietert PJ; Kavarana M; Moussa O; Burnette AL; Atz AM
    J Heart Lung Transplant; 2014 Dec; 33(12):1282-7. PubMed ID: 25128416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of
    Chowdhry M; Patel M; Thakur Y; Sharma V
    Asian J Transfus Sci; 2019; 13(2):136-139. PubMed ID: 31896922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic monitoring of the beneficial effect of one HLA-DR-shared blood transfusion in heart transplant patients.
    Vaessen LM; van Miert PP; van der Mast BJ; Doumaid K; Balk AH; Boog CJ; Weimar W
    J Heart Lung Transplant; 2000 Nov; 19(11):1098-107. PubMed ID: 11077228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.
    Battiwalla M; Ellis K; Li P; Pavletic SZ; Akpek G; Hematti P; Klumpp TR; Maziarz RT; Savani BN; Aljurf MD; Cairo MS; Drobyski WR; George B; Hahn T; Khera N; Litzow MR; Loren AW; Saber W; Arora M; Urbano-Ispizua A; Cutler C; Flowers ME; Spellman SR
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1302-8. PubMed ID: 22414493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
    Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
    J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.
    Willicombe M; Brookes P; Sergeant R; Santos-Nunez E; Steggar C; Galliford J; McLean A; Cook TH; Cairns T; Roufosse C; Taube D
    Transplantation; 2012 Jul; 94(2):172-7. PubMed ID: 22735711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
    Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.